1. Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms
   Saleheh Rezapour et al, 2019, Journal of Cellular Physiology CrossRef
2. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
   Dusan Ruzic et al, 2022, Pharmaceutics CrossRef
3. Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
   Jianglei Li et al, 2022, Frontiers in Pharmacology CrossRef
4. Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
   Bingyi Zhou et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
5. Ricolinostat suppresses proliferation, promotes apoptosis, and enhances the antiproliferative activity of topoisomerase inhibitors in cervical cancer cells
   Sumeet Kaur et al, 2022, Drug Development Research CrossRef
6. Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor
   Husvinee Sundaramurthi et al, 2022, Cancers CrossRef
7. MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells
   null Chen et al, 2019, Cancers CrossRef
8. Stress granules in colorectal cancer: Current knowledge and potential therapeutic applications
   Noémie Legrand et al, 2020, World Journal of Gastroenterology CrossRef
9. A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
   Xin-Hui Zhang et al, 2021, Journal of Medicinal Chemistry CrossRef
10. ACY-1215 suppresses the proliferation and induces apoptosis of chronic myeloid leukemia cells via the ROS/PTEN/Akt pathway
    Yuefeng Qin et al, 2022, Cell Stress and Chaperones CrossRef